| Fecha | Trimestre | Sesión | BPA (est → real) | Ingresos (est → reales) |
|---|---|---|---|---|
| 20 oct 2026Próximo | Q3 2026 | Antes de apertura | 6,47 | 12,1 B |
1 sept 2026
Thermo Fisher's EMPAD G2 detector enhances 4D STEM imaging speed, sensitivity and workflow integration, strengthening its Analytical Instruments portfolio.
WALTHAM, Mass., September 01, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 9:15 a.m. (ET).
Opportunities center on NGS, metagenomic profiling, portable field tests and cloud analytics, driven by viral outbreaks, precision agriculture, biosecurity and demand for early detection. Plant Virome Diagnostics Market Plant Virome Diagnostics Market Dublin, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The "Plant Virome Diagnostics Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global plant virome diagnostics market is experiencing strong growth as agricultural producers, re
Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. The new instruments target research in material science, environmental studies, geoscience, bioscience, and food authenticity. Consider looking at other stocks developing tools and infrastructure that support advanced...
31 ago 2026
Thermo Fisher Scientific has outperformed the Nasdaq over the past year, yet Wall Street analysts remain bullish on the stock, reflecting confidence that its strong growth trajectory has further room to run.
Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Biological Computing Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global biological computing market is experiencing exponential growth, supported by advances in DNA sequencing, synthetic biology, genomics research and bioinformatics. The market is projected to increase from $2.21 billion in 2025 to $2.90 billion in 2026, representing a compound annual growth rate (CAGR) of 31.2%. Historical biological computing marke
26 ago 2026
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.87% on an annualized basis producing an average annual return of 15.26%. Currently, Thermo Fisher Scientific has a market
Experts recommend Delta, Thermo Fisher, Target, and Interactive Brokers Group, Inc. due to strong earnings and guidance.
24 ago 2026
Amgen, Thermo Fisher and PepsiCo headline today's research, with growth drivers, strategic moves and key risks in focus.
23 ago 2026
Turnarounds in the healthcare sector do not all look the same. Some companies recover because management executes better, launches stronger products, and improves operations, while others do so because the industries they serve begin improving after prolonged downturns. Medtronic (NYSE:MDT) and Thermo Fisher Scientific (NYSE:TMO) are two of healthcare’s most closely watched recovery stories, but […]
Healthcare investors are often faced with a choice between companies that generate steady growth across diversified businesses and those positioned to benefit from improving industry conditions. Abbott Laboratories (NYSE:ABT) and Thermo Fisher Scientific (NYSE:TMO) represent those two approaches. Abbott (NYSE:ABT) continues to deliver broad-based growth across diagnostics, medical devices, and nutrition, while Thermo Fisher (NYSE:TMO) […]
